Apostolia-Maria Tsimberidou

45PUBLICATIONS
241CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical genetics (excl. cancer genetics)Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (45)

|Jul 15, 2026
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.

|Jun 24, 2026
Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors.

|Jun 18, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.

|Feb 23, 2026
Concordance analysis of DNA and RNA profiling: The MD Anderson IMPACT2 study in precision oncology.

Stephanie T Schmidt, Mehmet A Baysal, Siqing Fu

|Aug 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase I Unit.

Camila Braganca Xavier, Clark R Andersen, JoAnn Lim

|Jul 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors.

Blessie Elizabeth Nelson, Filip Janku, Siqing Fu

Pageof 8

Frequent Collaborators

14 joint publications

Aung Naing

12 joint publications

Funda Meric-Bernstam

9 joint publications

Siqing Fu

7 joint publications

Vivek Subbiah